# Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System

> **NCT04500028** · PHASE4 · COMPLETED · sponsor: **Aswan University Hospital** · enrollment: 220 (actual)

## Conditions studied

- IUCD Complication

## Interventions

- **DRUG:** INH
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT04500028
- **Lead sponsor:** Aswan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-12-01
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2022-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04500028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04500028, "Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04500028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*